Related Experiment Videos
Antibiotic overkill of trauma victims?
D Hadjiminas1, W G Cheadle, D A Spain
1Department of Surgery, University of Louisville School of Medicine, KY.
American Journal of Surgery
|September 1, 1994
Summary
Antibiotic use in severe trauma patients was high and costly. Shorter antibiotic courses may offer similar outcomes with reduced expenses, warranting re-evaluation of current practices.
Area of Science:
- Trauma Care
- Infectious Disease Management
- Pharmacoeconomics
Background:
- Severe trauma patients often receive prolonged antibiotic therapy.
- The necessity and cost-effectiveness of extensive antibiotic use require scrutiny.
Purpose of the Study:
- To evaluate antibiotic usage and costs in a randomized trial comparing recombinant interferon-gamma (rIFN-gamma) with placebo in severely injured trauma patients.
- To assess the clinical evidence for shorter antibiotic courses in trauma care.
Main Methods:
- Prospective, randomized trial involving 212 severely injured trauma patients across four university hospitals.
- Observation of patients until death or hospital discharge.
- Assessment of antibiotic utilization, costs, and related complications.
Main Results:
- High and seemingly unjustifiable numbers of antibiotics were used, incurring significant costs.
- Serious antibiotic-related complications were infrequent despite extensive use.
- The study identified a substantial financial burden associated with current antibiotic regimens.
Conclusions:
- Current regular antibiotic administration protocols for severe trauma patients should be re-evaluated.
- Clinical evidence suggests shorter antibiotic courses may yield similar outcomes with considerably reduced expenses.
- Optimizing antibiotic strategies in trauma care can lead to significant cost savings.